SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,494 | +230.1% | 15,128 | +342.3% | 0.00% | +100.0% |
Q2 2023 | $15,903 | +105920.0% | 3,420 | +8.1% | 0.00% | – |
Q1 2023 | $15 | +36.4% | 3,165 | +135.7% | 0.00% | – |
Q4 2022 | $11 | -99.9% | 1,343 | -58.7% | 0.00% | – |
Q3 2022 | $18,000 | -40.0% | 3,250 | -43.0% | 0.00% | -100.0% |
Q2 2022 | $30,000 | +200.0% | 5,704 | +362.6% | 0.00% | – |
Q1 2022 | $10,000 | -87.7% | 1,233 | -77.3% | 0.00% | -100.0% |
Q4 2021 | $81,000 | +42.1% | 5,443 | +80.5% | 0.00% | 0.0% |
Q3 2021 | $57,000 | -10.9% | 3,015 | -12.2% | 0.00% | -50.0% |
Q2 2021 | $64,000 | -21.0% | 3,435 | -3.5% | 0.00% | +100.0% |
Q1 2021 | $81,000 | +80.0% | 3,561 | +70.6% | 0.00% | 0.0% |
Q4 2020 | $45,000 | -75.7% | 2,087 | -88.7% | 0.00% | -50.0% |
Q3 2020 | $185,000 | +249.1% | 18,415 | +167.6% | 0.00% | 0.0% |
Q2 2020 | $53,000 | +5200.0% | 6,882 | +6156.4% | 0.00% | – |
Q3 2019 | $1,000 | -92.9% | 110 | -90.8% | 0.00% | -100.0% |
Q2 2019 | $14,000 | +366.7% | 1,202 | +413.7% | 0.00% | – |
Q1 2019 | $3,000 | -93.9% | 234 | -95.8% | 0.00% | -100.0% |
Q4 2018 | $49,000 | – | 5,518 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |